- Home
- MRNS vs PRE Comparison
MRNS vs PRE Comparison
Compare MRNS & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNS
- PRE
- Stock Information
- Founded
- MRNS 2003
- PRE 2014
- Country
- MRNS United States
- PRE Hong Kong
- Employees
- MRNS N/A
- PRE N/A
- Industry
- MRNS Biotechnology: Pharmaceutical Preparations
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- MRNS Health Care
- PRE Industrials
- Exchange
- MRNS Nasdaq
- PRE Nasdaq
- Market Cap
- MRNS 76.0M
- PRE 66.0M
- IPO Year
- MRNS 2014
- PRE N/A
- Fundamental
- Price
- MRNS $1.39
- PRE $4.48
- Analyst Decision
- MRNS Buy
- PRE Buy
- Analyst Count
- MRNS 7
- PRE 1
- Target Price
- MRNS $8.00
- PRE $9.00
- AVG Volume (30 Days)
- MRNS 322.0K
- PRE 27.2K
- Earning Date
- MRNS 11-05-2024
- PRE 09-24-2024
- Dividend Yield
- MRNS N/A
- PRE N/A
- EPS Growth
- MRNS N/A
- PRE N/A
- EPS
- MRNS N/A
- PRE N/A
- Revenue
- MRNS $30,263,000.00
- PRE $23,232,037.00
- Revenue This Year
- MRNS $20.42
- PRE $1,436.84
- Revenue Next Year
- MRNS $57.03
- PRE N/A
- P/E Ratio
- MRNS N/A
- PRE N/A
- Revenue Growth
- MRNS 16.56
- PRE N/A
- 52 Week Low
- MRNS $1.05
- PRE $2.85
- 52 Week High
- MRNS $11.26
- PRE $8.07
- Technical
- Relative Strength Index (RSI)
- MRNS 52.73
- PRE 40.69
- Support Level
- MRNS $1.37
- PRE $4.32
- Resistance Level
- MRNS $1.43
- PRE $4.80
- Average True Range (ATR)
- MRNS 0.08
- PRE 0.40
- MACD
- MRNS 0.00
- PRE -0.01
- Stochastic Oscillator
- MRNS 41.67
- PRE 28.09
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.